CareCloud, Inc. (CCLD) - Q3 2024 10-Q Summary
Business Context and Reporting Period
CareCloud, Inc. is a healthcare information technology company providing technology-enabled revenue cycle management (RCM), cloud-based software (SaaS), and medical practice management services. The company operates two reportable segments: Healthcare IT and Medical Practice Management. This summary covers the quarterly period ended September 30, 2024.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 9M 2024 | YTD 9M 2023 |
|---|---|---|---|---|
| Net Revenue | $28.5 million | $29.3 million | $82.6 million | $88.6 million |
| Net Income (Loss) | $3.1 million | $(2.7) million | $4.6 million | $(5.0) million |
| Operating Income (Loss) | $3.3 million | $(2.0) million | $5.7 million | $(3.5) million |
| Net Loss Attributable to Common Shareholders | $(0.7) million | $(6.7) million | $(4.5) million | $(16.7) million |
| Cash and Cash Equivalents | $2.8 million | $6.4 million (YTD end) | $2.8 million | $6.4 million (YTD end) |
| Working Capital | $0.7 million | $(0.1) million (Dec 31, 2023) | $0.7 million | $(0.1) million (Dec 31, 2023) |
| Debt (Line of Credit) | $0 | $10.0 million (Dec 31, 2023) | $0 | $10.0 million (Dec 31, 2023) |
| Adjusted EBITDA | $6.8 million | $3.2 million | $16.9 million | $11.3 million |
Material Changes vs. Prior Period
- Revenue Decline: Net revenue decreased 3% in Q3 and 7% YTD compared to the prior year. The decline was primarily driven by a reduction in project-based professional services revenue and the loss of two large accounts acquired in 2020 that transitioned to their acquirers' systems.
- Profitability Improvement: The company returned to profitability, reporting net income of $3.1 million in Q3 and $4.6 million YTD, compared to net losses in the same periods in 2023. This turnaround is attributed to significant cost reductions.
- Expense Reduction: Total operating expenses decreased 19% in Q3 and 16% YTD. Direct operating costs fell 16% due to reduced headcount in the U.S. and Pakistan. Selling and marketing expenses dropped 41% QTD and 36% YTD.
- Debt Repayment: The company fully repaid its $10.0 million outstanding balance on its revolving line of credit during the nine months ended September 30, 2024.
- Dividend Suspension: Preferred stock dividends remain suspended since December 2023. Approximately $10.6 million in dividends are currently in arrears. The suspension saves approximately $1.1 million per month in cash outflows.
Guidance, Outlook, and Risks
- Liquidity and Going Concern: Management believes substantial doubt regarding the company's ability to continue as a going concern has been alleviated through cost-control measures, restructuring, and the suspension of preferred dividends. The company projects sufficient liquidity for the next 12 months.
- Restructuring: A restructuring plan initiated in late 2023 is ongoing, targeting approximately $22.0 million in annualized cost savings, with $16.0 million expected to be realized in 2024.
- Change Healthcare Incident: The company experienced operational disruptions due to the Change Healthcare cybersecurity incident in February 2024 but has resumed claims submission and determined there was no material financial impact on Q3 results.
- Debt Covenants: The company is in compliance with all covenants. In October 2024 (subsequent event), the credit line was reduced from $25 million to $10 million.
- Goodwill Impairment: No further goodwill impairment was recorded in 2024 following a $42.0 million charge in Q4 2023. However, a decline in stock price could trigger future impairment tests.
Investor Verification Checklist
- Dividend Arrears: Verify the total accumulated preferred dividends in arrears ($10.6 million) and the conditions required to resume payments.
- Revenue Concentration: Assess the impact of the loss of the two large accounts mentioned in the MD&A on future revenue stability.
- Cash Burn vs. Generation: Monitor the sustainability of positive operating cash flow ($15.4 million YTD) against capital expenditures and potential future dividend resumption.
- Offshore Operations: Review risks associated with offshore operations in Pakistan and Sri Lanka, which account for a significant portion of expenses and face regulatory and banking system risks.
- Debt Facility Terms: Confirm the terms of the reduced $10 million credit line and the impact of the October 2024 modification on future borrowing capacity.